Latest News

Deals this week: Ribomic, Puridify, Ferring Pharmaceuticals

Biopharmaceutical company Ribomic and biotechnology company Evec have both entered a research...

Deals this week: Ribomic, Puridify, Ferring Pharmaceuticals

M&As this week: Teledyne Technologies Incorporated, AddLife

Teledyne Technologies Incorporated has acquired Hanson Research...

M&As this week: Teledyne Technologies Incorporated, AddLife

Study finds chemotherapy drug combination may cause women to grow new eggs

Women treated with a common chemotherapy drug combination may cause them to subsequently grow more young eggs in their ovaries, according to a study conducted by University of...

Study finds chemotherapy drug combination may cause women to grow new eggs

SRI wins $150m contract to accelerate production of HIV-prevention products

SRI wins $150m contract to accelerate production of HIV-prevention products

Bristol-Myers Squibb's Opdivo approved to treat blood cancer in EU

Bristol-Myers Squibb's drug Opdivo (nivolumab) has been approved for use in the European Union (EU) to treat classical Hodgkin lymphoma (cHL), a type of blood...

Bristol-Myers Squibb's Opdivo approved to treat blood cancer in EU

AbbVie partners with Johns Hopkins University for cancer research

AbbVie partners with Johns Hopkins University for cancer research

BTG launches DC Bead LUMI for liver cancer patients in Canada

BTG International has launched a next-generation treatment option, DC Bead LUMI, for cancer patients in Canada, marking its first worldwide market...

BTG launches DC Bead LUMI for liver cancer patients in Canada

UK's CMA fines Pfizer and Flynn Pharma nearly £90m for unfair pricing of epilepsy drug

UK's CMA fines Pfizer and Flynn Pharma nearly £90m for unfair pricing of epilepsy drug

Melbourne scientists develop first therapeutic dental vaccine

Melbourne scientists develop first therapeutic dental vaccine

New Myeloma Genome Project established to advance diagnosis and treatments

Celgene, the Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences have collaboratively launched a new initiative known as the Myeloma Genome...

New Myeloma Genome Project established to advance diagnosis and treatments

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

GSK finalises agreement with Brazilian MoH for Tivicay supply

GSK finalises agreement with Brazilian MoH for Tivicay supply

UK scientists create map of licensed drugs to search for future treatments

UK-based scientists at the Institute of Cancer Research (ICR) have created a map of all 1,578 licensed drugs and their mechanisms of action to identify ‘uncharted waters’ in the search for...

UK scientists create map of licensed drugs to search for future treatments

EIB to support Amryt Pharma’s new treatment for skin disorders

The European Investment Bank (EIB) will grant a €20m loan to support a new treatment being developed by Irish company Amryt Pharma for skin disorders....

EIB to support Amryt Pharma’s new treatment for skin disorders

Cancer Research UK to invest £226m in cancer research

Cancer Research UK to invest £226m in cancer research

M&As this week: Thermo Fisher Scientific, Heptares Therapeutics

Thermo Fisher Scientific has announced its decision to acquire MTI-GlobalStem. Pursuant to the acquisition, MTI-GlobalStem will be merged into Thermo Fisher’s life sciences solution...

M&As this week: Thermo Fisher Scientific, Heptares Therapeutics

NICE recommends GSK's new injectable asthma drug Nucala

NICE recommends GSK's new injectable asthma drug Nucala

Deals this week: Genetic Analysis, Boehringer Ingelheim, Vigene Biosciences

Genetic Analysis and Bio-Rad Laboratories have entered an agreement to further develop GA-map technology in routine...

Deals this week: Genetic Analysis, Boehringer Ingelheim, Vigene Biosciences

Rwanda becomes third country to launch Novartis Access programme

Novartis has announced that Rwanda signed a memorandum of understanding (MoU) and became the third country after Kenya and Ethiopia to launch the Novartis Access programme....

Rwanda becomes third country to launch Novartis Access programme

Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany

Takeda Pharmaceuticals has announced plans to invest more than €100m to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany....

Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany

New research says UK stroke patients can benefit from new treatment

New research has found that almost 10,000 UK stroke patients admitted to hospital each year could benefit from a new...

New research says UK stroke patients can benefit from new treatment